These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24385776)

  • 41. [Tryptase relation to VEGF in acute leukemia].
    Li Y; Zhang R; Lu XL; Wang PP; Fan H; Lü XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):793-7. PubMed ID: 16277844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
    Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis.
    Guo B; Liu Y; Tan X; Cen H
    Leuk Lymphoma; 2013 Jul; 54(7):1418-25. PubMed ID: 23157271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
    Liersch R; Schliemann C; Bieker R; Hintelmann H; Buechner T; Berdel WE; Mesters RM
    Leuk Res; 2008 Jun; 32(6):954-61. PubMed ID: 18006056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia.
    Fiedler W; Mesters R; Tinnefeld H; Loges S; Staib P; Duhrsen U; Flasshove M; Ottmann OG; Jung W; Cavalli F; Kuse R; Thomalla J; Serve H; O'Farrell AM; Jacobs M; Brega NM; Scigalla P; Hossfeld DK; Berdel WE
    Blood; 2003 Oct; 102(8):2763-7. PubMed ID: 12843001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis.
    Song M; Wang H; Ye Q
    Syst Rev; 2020 May; 9(1):103. PubMed ID: 32375879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of Lysosomal Membrane Proteins LAMP1, TPC1 and TPC2 in Acute Myeloid Leukemia Cells and Its Clinical Significance].
    Wang X; Ling BQ; Dai MF; Wang XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1046-1052. PubMed ID: 31418355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of neuropilin-1 expression in acute myeloid leukemia.
    Sallam TH; El Telbany MA; Mahmoud HM; Iskander MA
    Turk J Haematol; 2013 Sep; 30(3):300-6. PubMed ID: 24385810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy.
    Mehralizadeh H; Aliparasti MR; Talebi M; Salekzamani S; Almasi S; Raeisi M; Yousefi M; Movassaghpour A
    Adv Pharm Bull; 2021 Jan; 11(1):197-203. PubMed ID: 33747867
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence of increased angiogenesis in patients with acute myeloid leukemia.
    Hussong JW; Rodgers GM; Shami PJ
    Blood; 2000 Jan; 95(1):309-13. PubMed ID: 10607717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Relationship between VEGF and MMP-2, MMP-9 in 82 patients with acute myeloid leukemia].
    Yang L; Dong ZR; Wen SP; Pan L; Zhang XJ; Luo JM; Xu SR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):15-20. PubMed ID: 16584583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.
    Kiani-Zadeh M; Rezvany MR; Namjoo S; Barati M; Mohammadi MH; Ghasemi B; Tabatabaei T; Ghavamzadeh A; Zaker F; Teimoori-Toolabi L
    Mol Biol Rep; 2022 Aug; 49(8):7849-7862. PubMed ID: 35733068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of cysteine rich 61 and vascular endothelial growth factor genes in patients with myelodysplastic syndromes and their relationship.].
    Wang ZM; Cong YQ; Ma LN; Hu XJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):745-8. PubMed ID: 20137309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Ramzi M; Khalafi-Nezhad A; Iravani Saadi M; Jowkar Z
    Int J Hematol Oncol Stem Cell Res; 2018 Oct; 12(4):303-312. PubMed ID: 30774831
    [No Abstract]   [Full Text] [Related]  

  • 58. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
    Böhm A; Aichberger KJ; Mayerhofer M; Herrmann H; Florian S; Krauth MT; Derdak S; Samorapoompichit P; Sonneck K; Vales A; Gleixner KV; Pickl WF; Sperr WR; Valent P
    Eur J Clin Invest; 2009 May; 39(5):395-405. PubMed ID: 19320940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wilms' tumor gene (WT1) expression correlates with vascular epithelial growth factor (VEGF) in newly acute leukemia patients undergoing chemotherapy.
    Iranparast S; Assarehzadegan MA; Heike Y; Hossienzadeh M; Khodadadi A
    Asian Pac J Cancer Prev; 2014; 15(21):9217-23. PubMed ID: 25422204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
    Spiekermann K; Faber F; Voswinckel R; Hiddemann W
    Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.